Shareholders of Israeli technology firm Elbit last week approvedthe Haifa company's acquisition of the Elscintec ultrasound businessof Elscint, an Elbit subsidiary. Elbit proposed the acquisitionlate last year (SCAN 12/27/95). Elbit continues to study a
Shareholders of Israeli technology firm Elbit last week approved
the Haifa company's acquisition of the Elscintec ultrasound business
of Elscint, an Elbit subsidiary. Elbit proposed the acquisition
late last year (SCAN 12/27/95). Elbit continues to study a plan
to spin off Elbit into three separate firms, including one that
would consolidate the healthcare operations of Elbit and Elscint.
Seven Takeaways from New Analysis of Malpractice Cases Involving Interventional Radiologists
September 27th 2023Thirty-five percent of the interventional radiology malpractice cases involved vascular procedures and 26 percent of overall malpractice cases that went to trial resulted in plaintiff judgments with the average award being over $2 million.
CMS Issues New Reimbursement Code for PSMA PET Agent POSLUMA
September 26th 2023The transitional pass-through payment reimbursement code for the FDA-approved PSMA PET agent for prostate cancer detection will be effective as of October 1, according to the Centers for Medicare and Medicare Services (CMS).
New Multicenter Study Shows Viability of AI Tool for Detecting Central PE on CT
September 22nd 2023The Pulmonary Embolism (PE) Triage and Notification (PETN) module with RapidAI’s RapidPE platform reportedly demonstrated over 90 percent sensitivity and specificity rates for detection of central PE on computed tomography (CT), according to multicenter study findings presented at the 9th Annual Pulmonary Embolism Symposium.
2 Clarke Drive
Cranbury, NJ 08512